Dr. Ahmed Alaa Elbanna, DO

Dr. Elbanna practices at Gastro MD Florida in Orange City, Florida.

Dr. Elbanna's NPI, 1003279761, was assigned on March 31, 2016. Dr. Elbanna graduated from Michigan State University College Of Osteopathic Medicine in 2016. Dr. Elbanna holds Florida license OS20018.

Dr. Elbanna's primary practice is Gastro MD Florida, at 2884 Wellness Ave, Orange City, FL 32763 in Volusia County. The practice phone is (386) 668-2221.

Dr. Elbanna's primary practice is Gastro MD Florida in Orange City, Florida. Dr. Elbanna is also affiliated with AdventHealth Fish Memorial. The medical group on file is Gastroenterology Associates of Southwest Florida. Dmand AI also links Dr. Elbanna to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elbanna practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Elbanna's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Elbanna is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Elbanna's licenses on file in 2 states: Florida and Michigan.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroduodenitis, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Elbanna treats.

CMS data shows 1,572 Medicare services from Dr. Elbanna across 21 procedure codes in 2024, for 518 Medicare patients. Medicare paid $124,625 for them.

CMS counts 518 Medicare patients who saw Dr. Elbanna in 2024. The largest group is 65 to 74, with 233 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elbanna's median patient age at 61, with 55% women.

In 2024, Dr. Elbanna wrote 640 Medicare Part D claims for 289 patients. 83% of them were for generic drugs. CMS names the drug for 462 of them, across 10 drugs with 11 or more claims each, at $41,618 in total drug cost. In 2023, CMS named 152 claims across 6 drugs.

Dr. Elbanna accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 154 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Elbanna, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Elbanna, published from 2020 to 2023. 2020 was the busiest year, with 2. Dr. Elbanna's most frequent co-authors are Hussayn Joseph Alrayes, DO, Mouhanna Khaled Mahmoud Abu Ghanimeh, MD and Cyrus Ramin Piraka, MD.

CMS Open Payments shows 134 general payments to Dr. Elbanna from 29 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 74% of the total. Olympus Corporation of the Americas paid the most, $791.

Dr. Elbanna graduated from Michigan State University College Of Osteopathic Medicine in 2016.

Dr. Elbanna is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.